QuantumCyte introduced a digital pathology workflow designed to boost tumor purity on biopsy slides, addressing a common bottleneck in solid-tumor sequencing. The platform uses AI to outline tumors and mask surrounding healthy tissue before DNA extraction, aiming to increase actionable sequencing results for patients who otherwise fall below tumor-DNA purity thresholds.